Xvivo Perfusion AB
XVIVO.ST
#6804
Rank
ยฃ0.46 B
Marketcap
ยฃ14.72
Share price
-0.70%
Change (1 day)
-55.49%
Change (1 year)
Categories

Revenue for Xvivo Perfusion AB (XVIVO.ST)

Revenue in 2025 (TTM): ยฃ61.65 Million

According to Xvivo Perfusion AB's latest financial reports the company's current revenue (TTM ) is ยฃ60.66 Million. In 2024 the company made a revenue of ยฃ61.77 Million an increase over the revenue in the year 2023 that were of ยฃ44.51 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Xvivo Perfusion AB from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ61.65 M-0.2%
2024 ยฃ61.77 M38.78%
2023 ยฃ44.51 M33.06%
2022 ยฃ33.45 M53.66%
2021 ยฃ21.77 M47.59%
2020 ยฃ14.75 M-17.38%
2019 ยฃ17.85 M6.19%
2018 ยฃ16.81 M28.95%
2017 ยฃ13.03 M-0.33%
2016 ยฃ13.08 M35.89%
2015 ยฃ9.62 M24.96%
2014 ยฃ7.7 M19.89%
2013 ยฃ6.42 M